BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8503178)

  • 1. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M; Smith GL
    Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
    Wolffe EJ; Isaacs SN; Moss B
    J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
    Parkinson JE; Sanderson CM; Smith GL
    Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
    McIntosh AA; Smith GL
    J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
    Gurt I; Abdalrhman I; Katz E
    Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination.
    Mathew EC; Sanderson CM; Hollinshead R; Hollinshead M; Grimley R; Smith GL
    Virology; 1999 Dec; 265(1):131-46. PubMed ID: 10603324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
    Ortiz MA; Paez E
    Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
    Stern RJ; Thompson JP; Moyer RW
    Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
    Herrera E; Lorenzo MM; Blasco R; Isaacs SN
    J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
    Engelstad M; Howard ST; Smith GL
    Virology; 1992 Jun; 188(2):801-10. PubMed ID: 1585649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.
    Ward BM; Moss B
    J Virol; 2001 May; 75(10):4802-13. PubMed ID: 11312352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
    Mathew E; Sanderson CM; Hollinshead M; Smith GL
    J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
    Blasco R; Moss B
    J Virol; 1992 Jul; 66(7):4170-9. PubMed ID: 1602540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
    Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.
    Blasco R; Sisler JR; Moss B
    J Virol; 1993 Jun; 67(6):3319-25. PubMed ID: 8497053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
    Isaacs SN; Wolffe EJ; Payne LG; Moss B
    J Virol; 1992 Dec; 66(12):7217-24. PubMed ID: 1433514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and analysis of vaccinia virus palmitylproteins.
    Grosenbach DW; Hansen SG; Hruby DE
    Virology; 2000 Sep; 275(1):193-206. PubMed ID: 11017799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.